Advertisement

The Solitaire FR Revascularization Device by Covidien plc won approval for investigational use in the thromectomy part of the Interventional Management of Stroke (IMS III) trial, funded by the National Institute of Neurological Disorders and Stroke.

SOURCE

Advertisement
Advertisement